🔎 Trials Near Me

Beranda › Serangan Jantung › Tennessee

Uji klinis Serangan Jantung di Tennessee

5 studi untuk Serangan Jantung mencari peserta di lokasi di Tennessee.

Kota di Tennessee

Teks studi resmi (Bahasa Inggris)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Southeast Renal Research Institute, Chattanooga
  • Dialysis Clinic Inc - University Nephology, Knoxville
  • Knoxville Kidney Center PLLC, Knoxville
  • dan 2 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • The Stern Cardiovascular Foundation, Germantown
  • Apex Cardiology Research Associates of Jackson, Jackson
  • Vanderbilt Univ Medi Cen, Nashville
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Erlanger Health, Inc., Chattanooga
  • Ascension Saint Thomas, Nashville
  • Parkway Cardiology Associates, Oak Ridge
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04774159

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

  • University of Tennessee Medical Center, Knoxville
  • University of Tennessee Health Science Center/Regional One Health, Memphis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jan 2026 · NCT06374277

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.